M3-Brigade Acquisition V (NASDAQ:MBAV) Posts Quarterly Earnings Results

M3-Brigade Acquisition V (NASDAQ:MBAV) posted its earnings results on Thursday. The company reported $0.05 earnings per share for the quarter, FiscalAI reports.

M3-Brigade Acquisition V Trading Down 0.1%

MBAV traded down $0.02 during midday trading on Friday, reaching $10.80. 2,685 shares of the company’s stock traded hands, compared to its average volume of 34,945. The firm has a fifty day moving average of $10.78 and a two-hundred day moving average of $10.70. M3-Brigade Acquisition V has a 52 week low of $10.41 and a 52 week high of $13.73.

Analyst Ratings Changes

A number of equities research analysts have issued reports on MBAV shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of M3-Brigade Acquisition V in a research report on Friday, March 27th. Wall Street Zen upgraded shares of M3-Brigade Acquisition V to a “sell” rating in a research report on Saturday, March 14th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Saba Capital Management L.P. bought a new position in M3-Brigade Acquisition V during the 4th quarter valued at approximately $151,000. Hudson Bay Capital Management LP purchased a new position in shares of M3-Brigade Acquisition V during the fourth quarter valued at about $159,000. Prelude Capital Management LLC purchased a new position in shares of M3-Brigade Acquisition V during the third quarter valued at about $281,000. Sandia Investment Management LP purchased a new position in shares of M3-Brigade Acquisition V during the second quarter valued at about $334,000. Finally, Radcliffe Capital Management L.P. purchased a new position in shares of M3-Brigade Acquisition V during the third quarter valued at about $544,000.

M3-Brigade Acquisition V Company Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank?check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real?world data capabilities, combined with Brigade’s deep experience in credit and asset management.